Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells.

Bone marrow transplantation·2026
Same author

Impact of Renal Impairment and Lymphodepletion Regimen on Outcomes after CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma.

Transplantation and cellular therapy·2026
Same author

Preclinical evaluation of a novel CD4 specific CAR NK cell therapy for T-cell malignancies.

Cytotherapy·2026
Same author

Goals-of-care transition after an allogeneic hematopoietic stem-cell transplantation: A cross-sectional survey among hematologists on associated challenges.

Bone marrow transplantation·2026
Same author

Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.

HemaSphere·2026
Same author

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.

HemaSphere·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026
Same journal

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Human mutation·2026
Same journal

Comment on "When the Outcome Contains the Exposure: Methodological Limits of a Genome-Wide Cross-Trait Analysis of Type 2 Diabetes and MASLD".

Human mutation·2026
Same journal

AI-Augmented Hematological Signatures for Equitable Detection of Hereditary Hemolytic Anemia Carriers: A Global Systematic Review and Meta-Analysis.

Human mutation·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K

Semi-automated cancer genome analysis using high-performance computing.

Giuliano Crispatzu1,2, Pranav Kulkarni1, Mohammad R Toliat3

  • 1Bioinformatics Core Facility, Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Human Mutation
|June 10, 2017
PubMed
Summary
This summary is machine-generated.

QuickNGS Cancer streamlines next-generation sequencing (NGS) analysis for cancer genomics, overcoming hurdles in clinical research. This bioinformatics pipeline delivers rapid, reproducible results, identifying key cancer gene mutations efficiently.

Keywords:
analysis pipelinecancer genomicsmedical bioinformaticsnext-generation sequencing

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K
High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq
09:06

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

Published on: October 5, 2018

10.9K

Related Experiment Videos

Last Updated: Feb 28, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

20.0K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.3K
High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq
09:06

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

Published on: October 5, 2018

10.9K

Area of Science:

  • Bioinformatics
  • Genomics
  • Cancer Research

Background:

  • Next-generation sequencing (NGS) is now standard for cancer genome studies.
  • Existing bioinformatics tools require integration into efficient clinical workflows.
  • Analytical hurdles limit the broader application of NGS in clinical research.

Purpose of the Study:

  • Introduce QuickNGS Cancer, a bioinformatics pipeline suite for cancer genomics.
  • Reduce analytical challenges for clinically driven NGS research.
  • Enable efficient analysis of diverse NGS data types for cancer.

Main Methods:

  • Developed a suite of bioinformatics pipelines specifically for cancer genomics.
  • Incorporated methods to address cancer-specific issues like tumor impurity and aneuploidy.
  • Focused on assessing the biomedical relevance of genomic variations.

Main Results:

  • QuickNGS Cancer enables highly efficient analysis of various NGS data types.
  • Demonstrated reproducible analysis results within days of sequencing.
  • Reanalysis of 140 TCGA tumor/normal pairs identified missed mutations compared to existing pipelines.
  • Detected unexpected leukemia mutations confirmed by Sanger sequencing.

Conclusions:

  • QuickNGS Cancer significantly reduces analytical hurdles for NGS in cancer research.
  • Provides reproducible and clinically relevant results rapidly.
  • Enhances the applicability of NGS for clinical decision-making and discovery.